AFP and hepatocellular carcinoma: Though previous research has established the diagnostic and prognostic biomarkers for HCC alpha-fetoprotein (AFP), the reliability and accuracy of other biomarkers, including AFP-L3, osteopontin, and glypican-3 still need to be improved to detect HCC at an early stage [9, 10].